University of Cambridge > Talks.cam > Seminars on Quantitative Biology @ CRUK Cambridge Institute > RNAi libraries for high throughput phenotyping and drug resistance screening in the African trypanosome

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

RNAi libraries for high throughput phenotyping and drug resistance screening in the African trypanosome

Download to your calendar using vCal

If you have a question about this talk, please contact Florian Markowetz .

African trypanosomes are major pathogens of humans and livestock and represent a model for studies of unusual protozoal biology. We developed a high throughput phenotyping approach termed RNA interference (RNAi) target sequencing, or RIT -seq that, using Illumina sequencing, maps fitness-costs associated with RNAi. Analysis of bloodstream and insect life-cycle stages and differentiated libraries linked thousands of previously uncharacterised and ‘hypothetical’ genes to essential functions. The data-set also provides much needed genetic validation to identify new drug-targets. In a second application, all five current anti-trypanosomal drugs were used for RIT -seq screens, revealing the transporters, organelles, enzymes and metabolic pathways that function to facilitate anti-trypanosomal drug action.

This talk is part of the Seminars on Quantitative Biology @ CRUK Cambridge Institute series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

The Howard Theatre, Downing College, Cambridge Bateman Auditorium, Gonville & Caius G-R 03, English Faculty

Other talks

The elephant in the room: Machine Learning directly into physical models Afternoon Break Group Presentation 4 Title and abstract tba Title to be confirmed Optimal metric and approximation of free boundary minimal surfaces
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity